Switch theme
Sign up to access all valuation multiples
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments Front Shop and Pharma.
1986
n/a
LTM Revenue $2.6B
LTM EBITDA $427M
$4.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nahdi Medical has a last 12-month revenue of $2.6B and a last 12-month EBITDA of $427M.
In the most recent fiscal year, Nahdi Medical achieved revenue of $2.5B and an EBITDA of $430M.
Nahdi Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nahdi Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.5B | XXX | XXX | XXX |
| Gross Profit | n/a | $940M | XXX | XXX | XXX |
| Gross Margin | NaN% | 37% | XXX | XXX | XXX |
| EBITDA | $430M | $430M | XXX | XXX | XXX |
| EBITDA Margin | 19% | 17% | XXX | XXX | XXX |
| Net Profit | n/a | $238M | XXX | XXX | XXX |
| Net Margin | NaN% | 9% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Nahdi Medical's stock price is SAR 114 (or $30).
Nahdi Medical has current market cap of SAR 14.8B (or $4.0B), and EV of SAR 15.4B (or $4.1B).
See Nahdi Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.1B | $4.0B | XXX | XXX | XXX | XXX | $1.70 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Nahdi Medical has market cap of $4.0B and EV of $4.1B.
Nahdi Medical's trades at 1.6x LTM EV/Revenue multiple, and 9.6x LTM EBITDA.
Analysts estimate Nahdi Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nahdi Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $4.1B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 9.6x | XXX | XXX | XXX |
| P/E | 18.1x | XXX | XXX | XXX |
| P/E/Growth | 2.6x | XXX | XXX | XXX |
| EV/FCF | 13.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNahdi Medical's NTM/LTM revenue growth is 7%
Nahdi Medical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Nahdi Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nahdi Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nahdi Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 24% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 28% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nahdi Medical acquired XXX companies to date.
Last acquisition by Nahdi Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Nahdi Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Nahdi Medical founded? | Nahdi Medical was founded in 1986. |
| Where is Nahdi Medical headquartered? | Nahdi Medical is headquartered in Saudi Arabia. |
| Who is the CEO of Nahdi Medical? | Nahdi Medical's CEO is Mr. Yasser Ghulam Abdulaziz Joharji. |
| Is Nahdi Medical publicy listed? | Yes, Nahdi Medical is a public company listed on SAU. |
| What is the stock symbol of Nahdi Medical? | Nahdi Medical trades under 4164 ticker. |
| When did Nahdi Medical go public? | Nahdi Medical went public in 2022. |
| Who are competitors of Nahdi Medical? | Similar companies to Nahdi Medical include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of Nahdi Medical? | Nahdi Medical's current market cap is $4.0B |
| What is the current revenue of Nahdi Medical? | Nahdi Medical's last 12-month revenue is $2.6B. |
| What is the current EBITDA of Nahdi Medical? | Nahdi Medical's last 12-month EBITDA is $427M. |
| What is the current EV/Revenue multiple of Nahdi Medical? | Current revenue multiple of Nahdi Medical is 1.6x. |
| What is the current EV/EBITDA multiple of Nahdi Medical? | Current EBITDA multiple of Nahdi Medical is 9.6x. |
| What is the current revenue growth of Nahdi Medical? | Nahdi Medical revenue growth between 2023 and 2024 was 8%. |
| Is Nahdi Medical profitable? | Yes, Nahdi Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
